B.Riley Financial Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Raises Target Price to $20
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Maintains Target Price $30
B. Riley Raises Price Target on ClearPoint Neuro to $20 From $15, Keeps Buy Rating
ClearPoint Neuro Analyst Ratings
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Announces Target Price $30
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Announces Target Price $17
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating
Stifel Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Raises Target Price to $17
B.Riley Financial Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Raises Target Price to $15
B. Riley Adjusts Price Target on ClearPoint Neuro to $15 From $14, Maintains Buy Rating
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Raises Target Price to $15
Lake Street Reaffirms Their Buy Rating on ClearPoint Neuro (CLPT)
Lake Street Sticks to Their Buy Rating for ClearPoint Neuro (CLPT)
ClearPoint Neuro Analyst Ratings
Lake Street Maintains Buy on ClearPoint Neuro, Raises Price Target to $15